LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 81.20 | 770.25 | 12314 | 11766 | 1.0465 | 1.0233 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 81.20 | 770.25 | 9629 | 11766 | 0.8184 | 0.9006 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 83.42 | 770.25 | 12616 | 12031 | 1.0485 | 1.0241 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 83.42 | 770.25 | 9698 | 12031 | 0.8060 | 0.8941 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 85.64 | 770.25 | 12934 | 12287 | 1.0526 | 1.0258 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 85.64 | 770.25 | 9675 | 12287 | 0.7874 | 0.8839 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 87.86 | 770.25 | 13455 | 12543 | 1.0727 | 1.0352 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 87.86 | 770.25 | 9789 | 12543 | 0.7804 | 0.8805 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 3.21 | 770.25 | 887 | 904 | 0.9805 | 0.8374 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 3.21 | 770.25 | 809 | 904 | 0.8943 | 0.2356 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 5.44 | 770.25 | 946 | 1012 | 0.9341 | 0.6828 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 5.44 | 770.25 | 902 | 1012 | 0.8906 | 0.4916 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 7.66 | 770.25 | 1032 | 1090 | 0.9468 | 0.7932 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 7.66 | 770.25 | 939 | 1090 | 0.8615 | 0.4851 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 10.06 | 770.25 | 1120 | 1218 | 0.9192 | 0.7608 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 10.06 | 770.25 | 1068 | 1218 | 0.8765 | 0.6387 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 12.28 | 770.25 | 1285 | 1358 | 0.9462 | 0.8692 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 12.28 | 770.25 | 1212 | 1358 | 0.8924 | 0.7402 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 14.50 | 770.25 | 1413 | 1497 | 0.9437 | 0.8828 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 14.50 | 770.25 | 1362 | 1497 | 0.9097 | 0.8120 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 16.73 | 770.25 | 1513 | 1664 | 0.9090 | 0.8355 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 16.73 | 770.25 | 1476 | 1664 | 0.8868 | 0.7951 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 18.95 | 770.25 | 1598 | 1832 | 0.8720 | 0.7926 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 18.95 | 770.25 | 1533 | 1832 | 0.8366 | 0.7340 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 21.17 | 770.25 | 1721 | 2008 | 0.8569 | 0.7887 | MN20160304_L02 | F19 |